Shares of IBEX Limited (NASDAQ:IBEX – Get Free Report) have earned a consensus recommendation of “Hold” from the five analysts that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $19.80.
A number of research analysts have weighed in on the stock. Piper Sandler reaffirmed a “neutral” rating and issued a $17.00 price objective on shares of IBEX in a research note on Friday, February 9th. Truist Financial dropped their price objective on shares of IBEX from $25.00 to $22.00 and set a “buy” rating on the stock in a research note on Friday, February 9th. Finally, TheStreet lowered shares of IBEX from a “b-” rating to a “c+” rating in a research note on Wednesday, March 6th.
Get Our Latest Analysis on IBEX
Insider Activity at IBEX
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the company. Legal & General Group Plc lifted its position in shares of IBEX by 82.7% during the fourth quarter. Legal & General Group Plc now owns 1,047 shares of the company’s stock valued at $26,000 after purchasing an additional 474 shares in the last quarter. Amalgamated Bank increased its holdings in IBEX by 80.7% during the fourth quarter. Amalgamated Bank now owns 1,635 shares of the company’s stock worth $41,000 after buying an additional 730 shares during the last quarter. Point72 Middle East FZE purchased a new stake in IBEX during the second quarter worth about $43,000. Castleview Partners LLC purchased a new stake in IBEX during the first quarter worth about $59,000. Finally, Citigroup Inc. increased its holdings in IBEX by 325,600.0% during the second quarter. Citigroup Inc. now owns 3,257 shares of the company’s stock worth $69,000 after buying an additional 3,256 shares during the last quarter. 81.24% of the stock is owned by institutional investors.
IBEX Stock Up 2.8 %
Shares of NASDAQ IBEX opened at $15.43 on Friday. The firm has a market cap of $271.11 million, a PE ratio of 9.83 and a beta of 0.63. IBEX has a 12-month low of $11.45 and a 12-month high of $27.54. The company’s fifty day simple moving average is $16.09 and its 200 day simple moving average is $16.77.
IBEX (NASDAQ:IBEX – Get Free Report) last issued its earnings results on Thursday, February 8th. The company reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.10). IBEX had a return on equity of 20.10% and a net margin of 5.79%. The company had revenue of $132.63 million for the quarter, compared to the consensus estimate of $137.38 million. On average, equities analysts predict that IBEX will post 1.82 earnings per share for the current year.
About IBEX
IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience.
Further Reading
- Five stocks we like better than IBEX
- How to Use the MarketBeat Dividend Calculator
- 3 Value Stocks Too Small For Buffett’s Portfolio
- There Are Different Types of Stock To Invest In
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.